Cambridge Investment Research Advisors, Inc. Vaneck ETF Tr Vaneck Pharmaceu Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 3,421 shares of PPH stock, worth $316,921. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,421
Previous 44,213
92.26%
Holding current value
$316,921
Previous $4.2 Million
92.98%
% of portfolio
0.0%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding PPH
# of Institutions
149Shares Held
6.03MCall Options Held
14.5KPut Options Held
61.1K-
Goldman Sachs Group Inc New York, NY2.29MShares$212 Million0.03% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6512KShares$47.4 Million0.1% of portfolio
-
Avalon Trust CO Santa Fe, NM283KShares$26.2 Million1.74% of portfolio
-
J.Safra Asset Management Corp260KShares$24.1 Million1.87% of portfolio
-
Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management)200KShares$18.5 Million2.84% of portfolio